Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2023 Q1 2022 Q4, filed 15 May, long equity only

Download CSV Download Excel All activity


CRM, Salesforce	3.96%	Reduce −7.4%	3,501,838	$199.78	$700M	−279,000	+$198M
IQV, IQVIA	3.61%, was 4.38%	Reduce −1.5%	3,208,112	$198.89	$638M	−50,000	−$29M
TMO, Thermo Fisher Scientific	3.42%, was 4.19%	Reduce −9.7%	1,049,059	$576.37	$605M	−112,900	−$35M
Horizon Therapeutics Pub	3.35%	New	5,419,823	$109.14	$592M	+5,419,823	+$592M
GOOG, Alphabet	3.21%, was 1.76%	Add +80.3%	5,456,140	$104.00	$567M	+2,430,000	+$299M
TRU, Transunion	3.03%, was 3.30%	Reduce −2.8%	8,611,593	$62.14	$535M	−252,302	+$32M
MSFT, Microsoft	2.72%	Reduce −1.2%	1,667,478	$288.30	$481M	−21,000	+$76M
Shaw Communications	2.68%	New	15,800,000	$29.92	$473M	+15,800,000	+$473M
EXEL, Exelixis	2.58%, was 1.14%	Add +115.9%	23,466,000	$19.41	$455M	+12,597,851	+$281M
UNH, UnitedHealth Group	2.32%	New	866,000	$472.59	$409M	+866,000	+$409M
AZNN	2.30%, was 2.61%	Reduce −0.2%	5,867,553	$69.41	$407M	−8,909	+$8.8M
INTU, Intuit	2.30%	Add +1.0%	911,000	$445.83	$406M	+8,900	+$55M
ARMK, Aramark	2.28%	Add +3.8%	11,237,884	$35.80	$402M	+409,000	−$45M
SPGI, S&P Global	2.25%	Add +6.9%	1,151,900	$344.77	$397M	+74,800	+$36M
BSX, Boston Scientific	2.18%, was 2.81%	Reduce −16.8%	7,705,257	$50.03	$385M	−1,555,000	−$43M
YMM, Full Truck Alliance	1.89%	Add +0.8%	43,805,238	$7.61	$333M	+365,495	−$14M
DT, Dynatrace	1.86%, was 1.99%	Reduce −1.6%	7,788,269	$42.30	$329M	−130,000	+$26M
NOW, ServiceNow	1.84%, was 1.70%	Add +4.6%	699,650	$464.72	$325M	+31,000	+$66M
ELV, Elevance Health	1.75%	Add +6.2%	673,630	$459.81	$310M	+39,330	−$16M
CNC, Centene	1.71%	Add +4.0%	4,774,775	$63.21	$302M	+183,234	−$75M
HWM, Howmet Aerospace	1.66%, was 2.09%	Reduce −14.4%	6,941,527	$42.37	$294M	−1,165,826	−$25M
SHW, Sherwin-Williams	1.66%, was 2.16%	Reduce −5.7%	1,306,792	$224.77	$294M	−79,000	−$35M
WAB, Wabtec	1.63%	Add +4.4%	2,857,930	$101.06	$289M	+120,000	+$16M
EFX, Equifax	1.60%, was 2.17%	Reduce −18.0%	1,396,597	$202.84	$283M	−305,900	−$48M
BX, Blackstone	1.56%, was 1.58%	Reduce −3.4%	3,139,951	$87.84	$276M	−109,000	+$35M
MA, Mastercard	1.49%, was 2.09%	Reduce −20.7%	726,471	$363.41	$264M	−189,700	−$55M
AON, Aon	1.44%	Add +2.1%	804,686	$315.29	$254M	+16,600	+$17M
NYT, New York Times	1.40%, was 1.29%	Add +4.7%	6,354,791	$38.88	$247M	+286,000	+$50M
CSGP, CoStar Group	1.33%, was 1.16%	Add +49.6%	3,411,185	$68.85	$235M	+1,131,000	+$59M
V, Visa	1.29%, was 1.70%	Reduce −19.2%	1,009,410	$225.46	$228M	−239,600	−$32M
XYZ, Block	1.11%, was 1.33%	Reduce −11.1%	2,861,050	$68.65	$196M	−356,950	−$5.8M
BABA, Alibaba	1.04%, was 1.54%	Reduce −32.4%	1,800,000	$102.18	$184M	−861,000	−$50M
Oak Street Health	0.99%	New	4,503,076	$38.68	$174M	+4,503,076	+$174M
BIIB, Biogen	0.98%	Add +4.6%	619,798	$278.03	$172M	+27,099	+$8.2M
UTHR, United Therapeutics	0.84%	Add +1.4%	664,767	$223.96	$149M	+8,894	−$34M
Sarepta Therapeutics	0.71%, was 0.79%	Reduce −1.7%	913,300	$137.83	$126M	−15,600	+$5.5M
HUM, Humana	0.67%, was 0.91%	Reduce −9.5%	244,661	$485.46	$119M	−25,739	−$20M
Prometheus Biosciences	0.67%, was 0.10%	Add +658.7%	1,100,806	$107.32	$118M	+955,706	+$102M
Masimo	0.66%, was 0.74%	Reduce −16.7%	631,649	$184.54	$117M	−126,851	+$4.3M
BEAM, Beam Therapeutics	0.59%	Add +0.9%	3,431,921	$30.62	$105M	+32,000	−$28M
BEKE, KE Holdings	0.51%, was 0.53%	Reduce −17.4%	4,758,500	$18.84	$90M	−1,000,000	+$9.3M
PCG, PG&E	0.46%, was 0.55%	Reduce −2.9%	5,005,142	$16.17	$81M	−150,000	−$2.9M
Lufax	0.44%, was 0.49%	Reduce −0.4%	38,296,543	$2.04	$78M	−139,856	+$3.6M
PACB	0.42%, was 0.21%	Add +58.7%	6,355,120	$11.58	$74M	+2,350,720	+$41M
RVMD, Revolution Medicines	0.40%, was 0.27%	Add +93.4%	3,283,600	$21.66	$71M	+1,585,585	+$31M
ENTA, Enanta Pharmaceuticals	0.35%	Hold	1,550,000	$40.44	$63M	—	—
PTGX, Protagonist Therapeutics	0.34%	Reduce −28.4%	2,615,014	$23.00	$60M	−1,036,873	+$20M
INSP, Inspire Medical Systems	0.32%	Hold	242,596	$234.07	$57M	—	—
AGIO, Agios Pharmaceuticals	0.27%	Add +3.3%	2,092,829	$22.97	$48M	+67,000	−$8.8M
HCA, HCA Healthcare	0.23%	New	156,600	$263.68	$41M	+156,600	+$41M
MDGL, Madrigal Pharmaceuticals	0.22%	Add +7.1%	163,819	$242.26	$40M	+10,819	−$4.7M
BRKR, Bruker	0.22%, was 0.38%	Reduce −42.5%	494,476	$78.84	$39M	−364,824	−$20M
EVH, Evolent Health	0.21%, was 0.06%	Add +278.8%	1,143,909	$32.45	$37M	+841,909	+$29M
NTRA, Natera	0.21%, was 0.04%	Add +362.1%	661,783	$55.52	$37M	+518,583	+$31M
CYTK, Cytokinetics	0.19%, was 0.51%	Reduce −44.9%	938,072	$35.19	$33M	−763,666	−$45M
Reata Pharmaceuticals	0.17%	Reduce −2.1%	325,000	$90.92	$30M	−7,000	+$17M
Holding	0.16%	Hold	2,809,000	$10.15	$29M	—	—
Metals Acquisition	0.14%	Hold	2,489,700	$10.22	$25M	—	—
Berenson Acquisition	0.14%	Hold	2,475,000	$10.05	$25M	—	—
THC, Tenet Healthcare	0.13%	New	389,000	$59.42	$23M	+389,000	+$23M
JAZZ, Jazz Pharmaceuticals	0.12%, was 0.24%	Reduce −34.7%	150,000	$146.33	$22M	−79,800	−$15M
Savara	0.12%, was 0.10%	Add +7.6%	10,908,086	$1.95	$21M	+773,125	+$5.6M
APLS, Apellis Pharmaceuticals	0.12%, was 0.15%	Reduce −29.5%	317,553	$65.96	$21M	−132,847	−$2.3M
Maxar Technologies	0.12%	New	400,000	$51.06	$20M	+400,000	+$20M
Swiftmerge Acquisition	0.12%	Hold	1,980,000	$10.32	$20M	—	—
Zymeworks	0.10%, was 0.08%	Add +33.3%	2,000,000	$9.04	$18M	+500,000	+$6.3M
Sdcl Edge Acquisition	0.10%	Hold	1,732,500	$10.27	$18M	—	—
BNTX, Biontech	0.10%, was 0.14%	Reduce −1.7%	137,644	$124.57	$17M	−2,356	−$3.9M
Syneos Health	0.10%	New	472,000	$35.62	$17M	+472,000	+$17M
LNTH, Lantheus	0.09%	New	184,000	$82.56	$15M	+184,000	+$15M
Ares Acquisition	0.08%	Hold	1,425,000	$10.32	$15M	—	—
AVTR, Avantor	0.08%, was 0.07%	Add +28.9%	681,418	$21.14	$14M	+152,954	+$3.3M
Holding	0.08%	Hold	1,360,040	$10.22	$14M	—	—
TCV Acquisition	0.07%	Hold	1,211,459	$10.24	$12M	—	—
Iveric Bio	0.07%, was 0.21%	Reduce −66.8%	484,799	$24.33	$12M	−977,201	−$20M
Broadmark Realty Cap	0.06%, was 0.11%	Reduce −49.7%	2,437,995	$4.70	$11M	−2,412,005	−$5.8M
TPG Pace Beneficial II	0.06%	Hold	1,116,833	$9.97	$11M	—	—
COGT, Cogent Biosciences	0.06%, was 0.01%	Add +1055.1%	983,452	$10.79	$11M	+898,313	+$9.6M
BHVN, Biohaven	0.06%, was 0.09%	Reduce −25.0%	750,000	$13.66	$10M	−250,000	−$3.6M
Screaming Eagle Acquisitn	0.06%	Hold	1,000,000	$10.15	$10M	—	—
Churchill Capital Corporation VII	0.06%	Hold	1,000,000	$10.14	$10M	—	—
Churchill Capital Corporation VI	0.06%	Hold	997,767	$10.11	$10M	—	—
Cara Therapeutics	0.06%, was 0.15%	Reduce −3.8%	1,995,370	$4.91	$9.8M	−78,830	−$12M
Holding	0.05%	Hold	900,000	$10.50	$9.5M	—	—
RIO, Rio Tinto	0.05%	New	137,500	$68.60	$9.4M	+137,500	+$9.4M
Holding	0.05%	Hold	848,184	$10.12	$8.6M	—	—
Holding	0.05%	Hold	775,200	$10.42	$8.1M	—	—
Holding	0.04%	Hold	750,000	$10.25	$7.7M	—	—
Panacea Acquisition Corporation II	0.04%	Hold	750,000	$10.20	$7.7M	—	—
Holding	0.04%	Hold	745,000	$10.23	$7.6M	—	—
Corsair Partnering	0.04%	Hold	700,000	$10.26	$7.2M	—	—
Khosla Ventures Acquisition	0.04%	Hold	700,000	$10.14	$7.1M	—	—
ALVO, Alvotech	0.04%	Hold	500,000	$12.90	$6.5M	—	—
RCF Acquisition	0.04%	Hold	600,000	$10.46	$6.3M	—	—
VYGR, Voyager Therapeutics	0.03%	New	797,000	$7.71	$6.1M	+797,000	+$6.1M
Slam	0.03%	Hold	570,396	$10.33	$5.9M	—	—
VNET, Vnet Group	0.03%	Hold	1,775,000	$3.24	$5.8M	—	—
Blue Whale Acquisition	0.03%	Hold	575,000	$9.94	$5.7M	—	—
ICE, Intercontinental Exchange	0.03%	New	51,832	$104.29	$5.4M	+51,832	+$5.4M
Holding	0.03%, was 0.02%	Add +92.5%	1,560,500	$3.39	$5.3M	+750,000	+$2.6M
Holding	0.03%	Hold	502,001	$10.18	$5.1M	—	—
Gores Holdings IX	0.03%	Hold	500,000	$10.08	$5M	—	—
Atento	0.03%	Hold	2,230,357	$2.08	$4.6M	—	—
Lamf Global Ventures	0.02%	Hold	400,000	$10.45	$4.2M	—	—
Finserv Acquisition Corporation II	0.02%, was 0.04%	Reduce −33.3%	400,000	$10.09	$4M	−200,000	−$2M
Forest Road Acquisition Cor	0.02%, was 0.08%	Reduce −68.0%	400,000	$9.94	$4M	−850,000	−$8.6M
Cartica Acquisition	0.02%	Hold	350,000	$10.54	$3.7M	—	—
Holding	0.02%	Hold	350,000	$10.37	$3.6M	—	—
Uta Acquisition	0.02%	Hold	344,100	$10.41	$3.6M	—	—
Ambrx Biopharma	0.02%	New	361,000	$8.92	$3.2M	+361,000	+$3.2M
Sound Point Acquisition	0.02%	Hold	300,000	$10.55	$3.2M	—	—
Avrobio	0.02%	Add +321.1%	3,116,000	$1.00	$3.1M	+2,376,000	+$2.6M
NUVB, Nuvation Bio	0.01%, was 0.03%	Reduce −30.8%	1,465,000	$1.66	$2.4M	−652,600	−$1.6M
Provention Bio	0.01%	New	90,000	$24.10	$2.2M	+90,000	+$2.2M
Arya Sciences Acqu Corporation IV	0.01%, was 0.05%	Reduce −75.0%	200,000	$10.32	$2.1M	−600,000	−$6M
Marblegate Acquisition	0.01%	Hold	150,000	$10.07	$1.5M	—	—
ALNY, Alnylam Pharmaceuticals	0.01%, was 0.20%	Reduce −94.8%	6,719	$200.32	$1.3M	−123,337	−$30M
Blueprint Medicines	0.01%, was 0.03%	Reduce −76.1%	22,420	$44.99	$1M	−71,580	−$3.1M
NTRS, Northern Trust	0.01%	Hold	100,000	$10.07	$1M	—	—
OKLO, Altc Acquisition	0.01%	Hold	98,300	$10.15	$998K	—	—
Amyris	0.01%	Reduce −29.3%	706,700	$1.36	$961K	−293,300	−$569K
Summit Midstream Partners	0.01%	Add +35.2%	58,214	$15.35	$894K	+15,159	+$175K
Legend Biotech	0.00%, was 0.24%	Reduce −97.6%	17,600	$48.22	$849K	−729,014	−$36M
Clever Leaves	0.00%, was 0.01%	Reduce −27.8%	1,927,945	$0.3819	$736K	−740,606	−$83K
Better Therapeutics	0.00%, was 0.01%	Reduce −14.1%	699,042	$0.7280	$509K	−114,514	−$402K
EDU	0.00%	Hold	13,000	$38.61	$502K	—	—
Karuna Therapeutics	0.00%	Hold	2,200	$181.64	$400K	—	—

Showing top 50 of 127 by value

Exits / last held

Gone since 2022 Q4, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
ABBV, AbbVie	0.99%	Exit	$161.61	$152M	−939,212	−$152M
CLVT, Clarivate	0.83%	Exit	$8.34	$127M	−15,177,433	−$127M
CVS, CVS Health	0.42%	Exit	$93.19	$65M	−694,259	−$65M
Holding	0.12%	Exit	$10.02	$19M	−1,900,000	−$19M
Vector Acquisition Corporation II	0.11%	Exit	$10.10	$17M	−1,700,000	−$17M
Disruptive Acquisition	0.09%	Exit	$10.08	$14M	−1,400,000	−$14M
Agile Growth	0.08%	Exit	$10.09	$12M	−1,200,000	−$12M
Holding	0.07%	Exit	$10.10	$11M	−1,120,102	−$11M
FHN, First Horizon	0.07%	Exit	$24.50	$11M	−455,000	−$11M
Holding	0.07%	Exit	$10.10	$10M	−1,000,000	−$10M
Forum Merger IV	0.07%	Exit	$10.05	$10M	−1,000,000	−$10M
GPOR, Gulfport Energy	0.06%	Exit	$73.64	$8.5M	−116,020	−$8.5M
Holding	0.06%	Exit	$10.08	$8.4M	−835,638	−$8.4M
Holding	0.05%	Exit	$10.10	$8.1M	−800,000	−$8.1M
Levere	0.05%	Exit	$10.09	$8.1M	−800,000	−$8.1M
Holding	0.05%	Exit	$10.25	$7.7M	−750,000	−$7.7M
Holding	0.05%	Exit	$10.09	$7.6M	−750,000	−$7.6M
Pathfinder Acquisition	0.05%	Exit	$10.07	$7.6M	−750,000	−$7.6M
Holding	0.05%	Exit	$10.08	$7.1M	−700,000	−$7.1M
Rocket Internet Grwt Oprt	0.04%	Exit	$10.10	$6.5M	−647,945	−$6.5M
Holding	0.04%	Exit	$10.25	$6.2M	−600,000	−$6.2M
Ftac Hera Acquisition	0.03%	Exit	$10.12	$5.1M	−500,000	−$5.1M
G Squared Ascend	0.03%	Exit	$10.11	$5.1M	−500,000	−$5.1M
Holding	0.03%	Exit	$10.07	$5M	−500,000	−$5M
Generation Bio	0.03%	Exit	$3.93	$4.9M	−1,249,382	−$4.9M
Holding	0.03%	Exit	$9.85	$4.8M	−484,709	−$4.8M
Scion Tech Growth II	0.03%	Exit	$10.12	$4.6M	−450,000	−$4.6M
LDH Growth	0.03%	Exit	$10.07	$4.4M	−436,702	−$4.4M
SVF Investment	0.03%	Exit	$10.11	$4.3M	−425,000	−$4.3M
VPC Impact Acquisition	0.03%	Exit	$10.11	$4.3M	−425,000	−$4.3M
Holding	0.03%	Exit	$10.16	$4.1M	−400,000	−$4.1M
Holding	0.03%	Exit	$10.05	$4M	−400,000	−$4M
Holding	0.02%	Exit	$10.29	$3.1M	−300,000	−$3.1M
Lazard Growth Acquisition	0.02%	Exit	$10.11	$3M	−300,000	−$3M
Live Oak Mobility Acquisi	0.02%	Exit	$10.06	$2.5M	−250,000	−$2.5M
Arctos Northstar Acquis	0.01%	Exit	$10.09	$2M	−200,000	−$2M
TNGX, Tango Therapeutics	0.01%	Exit	$7.25	$2M	−270,000	−$2M
Priveterra Acquisition	0.01%	Exit	$10.05	$1.5M	−150,000	−$1.5M
NTRS, Northern Trust	0.01%	Exit	$10.05	$1M	−100,000	−$1M
Opal Fuels	—	Exit	$7.28	$260K	−35,725	−$260K
Holding	—	Exit	$2.67	$229K	−85,838	−$229K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov